| Association between nocturnal hypoxemia and cancer incidence in patients investigated for OSA: data from a large multicenter French cohort G Justeau, C Gervès-Pinquié, M Le Vaillant, W Trzepizur, N Meslier, ... Chest 158 (6), 2610-2620, 2020 | 56 | 2020 |
| Anti-PD-(L) 1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials T Landre, G Justeau, JB Assié, K Chouahnia, C Davoine, C Taleb, ... Cancer Immunology, Immunotherapy 71 (3), 719-726, 2022 | 49 | 2022 |
| Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort B Ribeiro Baptista, T d’Humières, F Schlemmer, I Bendib, G Justeau, ... Respiratory Research 23 (1), 68, 2022 | 24 | 2022 |
| Cancer risk in patients with sleep apnoea following adherent 5-year CPAP therapy G Justeau, S Bailly, C Gervès-Pinquié, W Trzepizur, N Meslier, F Goupil, ... European Respiratory Journal 59 (4), 2022 | 20 | 2022 |
| Unexpected adverse events of immunotherapies in non-small cell lung cancer: About 2 cases G De Chabot, G Justeau, F Pinquié, A Nadaj-Pakleza, E Hoppé, ... Revue de Pneumologie Clinique 73 (6), 326-330, 2017 | 12 | 2017 |
| First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a … R Descourt, L Greillier, M Perol, C Ricordel, JB Auliac, L Falchero, ... Cancer Immunology, Immunotherapy 72 (1), 91-99, 2023 | 11 | 2023 |
| Benefits of semiology taught using near-peer tutoring are sustainable B Gripay, T André, M De Laval, B Peneau, A Secourgeon, N Lerolle, ... BMC medical education 22, 1-7, 2022 | 5 | 2022 |
| Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea G Justeau, C Gervès-Pinquié, M Jouvenot, T Pigeanne, S Launois, ... European Respiratory Journal 60 (1), 2022 | 5 | 2022 |
| Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for Obstructive Sleep Apnea: Data from a Large Multicenter French Cohort G Justeau, C Gervès-Pinquié, W Trzepizur, M Le Vaillant, N Meslier, ... D19. SRN: HEALTH CONSEQUENCES AND OUTCOMES OF OSA: WHAT DO'BIG DATA'AND …, 2020 | 5 | 2020 |
| Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy G Justeau, E Huchot, Y Simonneau, M Roa, J Le Treut, G Le Garff, ... Lung Cancer 174, 45-49, 2022 | 4 | 2022 |
| Facteurs de risque des cancers bronchiques: tabac, exposition professionnelle et environnementale T Urban, J Hureaux, G Justeau, G de Chabot Revue des Maladies Respiratoires Actualités 10 (3), 186-191, 2018 | 3 | 2018 |
| Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary … S Gendarme, S Zebachi, R Corre, L Greillier, G Justeau, O Bylicki, ... Journal of Geriatric Oncology, 101506, 2023 | 2 | 2023 |
| Sleep apnoea and cancer risk: Where are we now? G Justeau, F Gagnadoux Respiratory Medicine and Research 81, 100905-100905, 2022 | 2 | 2022 |
| First-line pembrolizumab monotherapy for PD-L1-positive (TPS≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric … R Descourt, L Greillier, M Perol, C Ricordel, JB Auliac, L Falchero, ... Journal of Clinical Oncology 39 (15_suppl), 9091-9091, 2021 | 2 | 2021 |
| Anti PD-(L) 1 in KRAS mutant advanced nsclcs: A meta-analysis of randomized controlled trials. T Landre, G Justeau, J Assié, K Chouahnia, C Taleb, C Chouaid, ... Journal of Clinical Oncology 39 (15_suppl), 9025-9025, 2021 | 2 | 2021 |
| Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study) JB Auliac, F Guisier, A Bizieux, P Assouline, M Bernardini, R Lamy, ... OncoTargets and therapy, 13299-13305, 2020 | 2 | 2020 |
| Effets secondaires inhabituels des immunothérapies dans le cancer bronchique non à petites cellules: à propos de deux cas G de Chabot, G Justeau, F Pinquié, A Nadaj-Pakleza, E Hoppé, ... Revue de Pneumologie Clinique 73 (6), 326-330, 2017 | 2 | 2017 |
| Quels sont les ingrédients de la motivation? G Justeau Revue des maladies respiratoires actualités 6 (3), 225-226, 2014 | 2 | 2014 |
| Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1≥ 50% advanced non small cell lung cancer H Doubre, L Greillier, G Justeau, C Ricordel, A Swalduz, H Curcio, ... Journal of Cancer Research and Clinical Oncology 149 (16), 15095-15102, 2023 | 1 | 2023 |
| Targeting p16 to induce Krt8+ transitional stem cell state and promote alveolar regeneration BR Baptista, G Justeau, M Toigo, M Zysman, CT De Menonville, ... European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
